Company intelligence / Profile preview

Keystone Capital Partners

New York City, New York, United Stateskstonepartners.com ↗

Ownership: Private
Development stage: Other

Overview

Keystone Capital Partners is a New York-based investment platform founded in 2019 that provides capital solutions for small and midsize public and private companies, with significant activity in biotech and healthcare. They invest through creative structures to support growth-stage companies but do not themselves develop therapeutics or diagnostics. Their portfolio includes investments in molecular diagnostics (Stella Diagnostics), regenerative medicine (PolarityTE), antibody therapies (Vaccinex), precision immunodiagnostics (Navidea Biopharmaceuticals), oncology drug development (Varian Biopharma), and addiction therapeutics (Adial Pharmaceuticals).

Industry: Investors

Beyond the preview

Go deeper on Keystone Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keystone Capital Partners.

Explore the full profile